Can Flagyl (metronidazole) or ciprofloxacin cause diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Flagyl or Ciprofloxacin Cause Diarrhea?

Yes, both Flagyl (metronidazole) and ciprofloxacin can cause diarrhea as a side effect, though the mechanisms and clinical significance differ substantially between these two antibiotics.

Ciprofloxacin and Diarrhea

Ciprofloxacin causes diarrhea through two distinct mechanisms:

Direct Gastrointestinal Side Effect

Diarrhea is a common adverse effect of ciprofloxacin, occurring in approximately 1.6% of patients in clinical trials 1. The FDA drug label lists diarrhea among the most frequently reported drug-related events across all formulations and indications 1. In pediatric trials, gastrointestinal events (including diarrhea) occurred in 15% of ciprofloxacin-treated patients compared to 9% in comparator groups 1.

Clostridium difficile-Associated Diarrhea (CDAD)

More seriously, ciprofloxacin can trigger C. difficile-associated diarrhea (CDAD), which may range from mild diarrhea to fatal colitis 1. The FDA explicitly warns that CDAD has been reported with ciprofloxacin use and can occur over two months after antibiotic administration 1. However, older research suggests ciprofloxacin is less likely than other antibiotics to promote C. difficile overgrowth, with MIC values of 8-32 mg/L showing it doesn't support C. difficile growth in vitro 2.

Critical caveat: If a patient on ciprofloxacin develops diarrhea, you must consider CDAD in your differential. The FDA mandates that ongoing ciprofloxacin use should be discontinued if CDAD is suspected, with appropriate fluid management, protein supplementation, and C. difficile-directed therapy instituted 1.

Metronidazole and Diarrhea

The relationship between metronidazole and diarrhea is paradoxical:

As a Side Effect

Diarrhea is a well-documented side effect of metronidazole, occurring in approximately 20% of patients 3. In a prospective study of 155 women treated with oral metronidazole 400 mg twice daily for 7 days, 20% (31/154) reported diarrhea, with most cases starting within 3 days of treatment and resolving within 5 days of onset 3. The broader literature confirms metronidazole is "well tolerated with mild to moderate side effects such as nausea, abdominal pain, and diarrhea" 4.

The Paradox: Treatment vs. Cause

Remarkably, metronidazole is simultaneously used to TREAT C. difficile-associated diarrhea while also being capable of CAUSING it 5. The WHO guidelines list oral metronidazole as an Access antibiotic for C. difficile infections 5. However, a 1980 case report documented a patient who developed C. difficile colitis while taking metronidazole for trichomonal vaginitis, despite the isolated C. difficile strain being sensitive to metronidazole at 0.25 μg/ml 6. This demonstrates that metronidazole can disrupt normal gut flora sufficiently to allow C. difficile overgrowth, even though it has activity against the organism.

Clinical Algorithm for Managing Diarrhea on These Antibiotics

When a patient develops diarrhea while taking either medication:

  1. Assess severity and timing: Mild diarrhea within 3-5 days of starting treatment that resolves quickly is likely a direct drug effect 3

  2. Red flags for CDAD: Persistent diarrhea beyond 5 days, fever, abdominal pain, or bloody stools warrant immediate stool testing for C. difficile toxin 1

  3. For ciprofloxacin: Consider discontinuation if CDAD suspected, as the FDA explicitly recommends stopping antibiotics not directed against C. difficile 1

  4. For metronidazole: The decision is more complex since it treats C. difficile—if CDAD is confirmed, metronidazole may be continued as definitive therapy 5

  5. Treatment discontinuation rates: Only 3% of metronidazole patients discontinue due to adverse effects 3, while 1% of ciprofloxacin patients discontinue for any adverse event 1

Key Takeaway

Both antibiotics cause diarrhea, but approach each differently: ciprofloxacin-associated diarrhea should prompt immediate consideration of CDAD and potential discontinuation, while metronidazole-associated diarrhea is usually self-limited but creates the clinical paradox of potentially causing the very condition it treats.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.